Regarding asthma, further studies and clinical trials are needed to evaluate the efficacy of add-on therapy with lichochalcone A, bevacizumab, diosmetin, epigallocatechin gallate, IGFBP-3, Neovastat, endostatin, PEDF, and melatonin. This evidence concerns the gene SERPINF1 and asthma.